Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03122522
Title A Study to Evaluate Adaptive Dosing of Ipilimumab and Nivolumab Combination Immunotherapy
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Hartford Healthcare Alliance (Data Collection Only) Hartford Connecticut 06102 United States Details
Jaykumar Thumar Hartford Connecticut 06102 United States Details
JOHNS HOPKINS HOSPITAL (Data Analysis Only) Baltimore Maryland 21287 United States Details
Brigham and Women's Hospital (Data and Specimen Analysis Only) Boston Massachusetts 02115 United States Details
Memorial Sloan Kettering Basking Ridge Basking Ridge New Jersey 07920 United States Details
Memorial Sloan Kettering Monmouth Middletown New Jersey 07748 United States Details
Memorial Sloan Kettering Bergen Montvale New Jersey 07645 United States Details
Memorial Sloan Kettering Commack Commack New York 11725 United States Details
Memorial Sloan Kettering Westchester Harrison New York 10604 United States Details
Hospital for Special Surgery (Data Analysis) New York New York 10021 United States Details
Columbia University (Data Analysis Only) New York New York 10032 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Memorial Sloan Kettering Nassau Uniondale New York 11553 United States Details
Lehigh Valley Health Network (Data Collection Only) Allentown Pennsylvania 18103 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field